Allergy Therapeutics plc (AGY.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 378.93M |
| Enterprise Value | 426.23M |
| P/E Ratio | -5.05 |
| PEG Ratio | 0.36 |
| Price/Sales Ratio | 5.53 |
| Price/Book Ratio | 61.48 |
| Enterprise/Revenue | 5.82 |
| Enterprise/EBITDA | -10.18 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.85 |
| Operating Margin | -0.6 |
AD
Management Effectiveness
| Return On Assets | -0.69 |
| Return On Equity | 4.09 |
Income Statement
| Revenue | 55.04M |
| Revenue/Share | 0.01 |
| Gross Profit | 25.13M |
| EBITDA | -29.43M |
| Net Income | -40.13M |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 10.08M |
| Total Cash/Share | 0 |
| Total Debt | 26.75M |
| Total Debt/Equity | 6.3 |
| Current Ratio | 1.13 |
| Book Value Per Share | 0 |
Price History
| 52-Week Change | -39.76 |
| 52-Week High | 12.1 |
| 52-Week Low | 4.5 |
| Moving Average 50 Days | 5.74 |
| Moving Average 200 Days | 9.21 |
Statistics
| Average Volume | 516,824 |
| Shares Outstanding | 6.33B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 63:29 |
| Last Split Date | September 28, 2023 |
AD
